Patients are losing out because the rules governing research are designed to restrain rather than facilitate. Its got to change, says Roger Stupp, who is frustrated that 10 years after helping set a new standard [more]
When new cancer therapies regularly become available more than half a year earlier in the US than in Europe, or get regulatory approval on one side of the Atlantic but not on the other, patients [more]
It was stumbling across a poster for a meeting about cancer in the developing world that turned journalist Joanne Silberner from a sceptic into a believer, and prompted her to do her bit to change [more]
With health budgets flat-lining and demand for healthcare rising, the only way Europe can improve patient outcomes is by finding new ways to do things better. But who will champion innovation in cancer care and [more]
Imaging techniques used in staging and evaluation of response to treatment have improved dramatically over the past 120 years. The issue going forward will be learning to combine anatomical and functional imaging modalities to get [more]
Two practitioners of integrative oncology make the case for using non-traditional therapies alongside mainstream care and for abandoning the term complementary and alternative medicine as unhelpful and misleading in this comprehensive article, which [more]
Bettina Ryll is a patient advocate and founding member of the Independent Melanoma Community Advisory Board. A qualified doctor, with a PhD in molecular biology, she gained a deeper insight into the reality of cancer, [more]